华大基因(300676) - 2017 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders rose by 12.46% to CNY 121,365,273.07 for the reporting period[7] - Operating revenue for the period was CNY 558,460,020.50, reflecting a growth of 13.78% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 28.20% to CNY 101,526,140.74[7] - Basic earnings per share for the period was CNY 0.31, up 3.33% compared to the same period last year[7] - The weighted average return on equity decreased by 0.17 percentage points to 3.17%[7] - Net profit for the third quarter reached CNY 131,762,643.99, compared to CNY 119,000,722.83 in the previous year, reflecting a growth of approximately 10.7%[37] - The net profit attributable to shareholders of the parent company was CNY 121,365,273.07, up from CNY 107,920,759.88, marking an increase of around 12.4%[37] - Basic earnings per share for the third quarter were CNY 0.31, slightly up from CNY 0.30 in the same quarter last year[38] - The company reported a total comprehensive income of CNY 131,866,156.91 for the quarter, compared to CNY 123,334,846.97 in the previous year, an increase of about 6.2%[38] Assets and Liabilities - Total assets increased by 17.55% to CNY 4,972,624,034.75 compared to the end of the previous year[7] - The total liabilities increased to CNY 820,992,315.44 from CNY 777,521,420.39[30] - The company's equity attributable to shareholders rose to CNY 4,044,325,652.50, compared to CNY 3,359,761,999.47 in the previous period[31] - Accounts receivable increased by 31.68% to ¥806,273,133.84 due to revenue growth during the reporting period[17] - Inventory rose by 81.64% to ¥133,674,925.57 as a result of expanded sales and increased raw material reserves[17] - Short-term borrowings increased by 166.67% to ¥8,000,000.00, primarily due to additional bank loans taken by subsidiaries[17] - The company’s retained earnings increased to CNY 621,291,231.19 from CNY 428,886,999.79[31] - The company’s capital reserve increased to CNY 2,961,760,415.45 from CNY 2,520,985,989.03[30] - The company’s total non-current assets reached CNY 1,209,621,174.21, compared to CNY 1,027,752,726.33 in the previous period[30] Cash Flow - Cash flow from operating activities showed a significant decline of 52.87% to CNY 79,831,657.59 year-to-date[7] - Cash generated from operating activities decreased by 52.87% to ¥79,831,657.59, influenced by increased purchases corresponding to sales growth[18] - The total cash flow from financing activities was ¥373,348,156.67, significantly improving from a negative cash flow of ¥93,227,475.51 in the previous period[18] - Cash inflow from financing activities totaled 494,195,200.00 CNY, with a net cash flow of 372,874,426.42 CNY, compared to -82,800,000.00 CNY previously[55] - The ending balance of cash and cash equivalents was 112,429,881.84 CNY, significantly higher than 33,701,365.74 CNY at the end of the previous period[55] - The cash and cash equivalents net increase was -196,400,300.90 CNY, compared to -149,114,516.54 CNY in the prior period[55] Shareholder Information - The total number of shareholders at the end of the reporting period was 30,584[11] - The largest shareholder, Shenzhen BGI Technology Co., Ltd., held 37.18% of the shares[11] Non-Recurring Gains and Expenses - The company reported non-recurring gains totaling CNY 47,632,301.76 for the year-to-date[9] - The company’s financial expenses increased by 272.54% to ¥7,251,413.57, mainly due to foreign exchange rate fluctuations[17] - The company did not declare any profit distribution during the reporting period, maintaining its cash dividend policy[22] Operational Costs - Total operating costs amounted to CNY 1,096,653,196.93, up from CNY 1,001,561,412.84, indicating an increase of about 9.5%[43] - Sales expenses for the quarter were CNY 96,809,285.86, a decrease from CNY 100,183,208.66, showing a reduction of approximately 3.7%[37] - Management expenses decreased to CNY 74,567,089.98 from CNY 94,974,645.87, indicating a reduction of about 21.5%[37] Investment Activities - The company reported a significant increase in accounts payable, which rose to CNY 181,200,372.80 from CNY 57,924,494.53[30] - The company completed its initial public offering (IPO) of 40.1 million shares on July 14, 2017, on the Shenzhen Stock Exchange[19] - The company recorded a foreign exchange loss of CNY 7,463,471.85 in Q3 2017, compared to a gain of CNY 9,824,359.81 in the same period last year[46] - Total cash inflow from investment activities was 4,519,099,337.80 CNY, up from 3,211,622,034.32 CNY year-over-year[54] - Total cash outflow from investment activities was 4,955,066,026.47 CNY, an increase from 3,308,275,248.79 CNY year-over-year[54]